Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Dualistic Role of BARD1 in Cancer.

Cimmino F, Formicola D, Capasso M.

Genes (Basel). 2017 Dec 8;8(12). pii: E375. doi: 10.3390/genes8120375. Review.

2.

CASC15 gene polymorphisms reduce neuroblastoma risk in Chinese children.

Zhang J, Zhuo ZJ, Wang J, He J, Yang L, Zhang D, Qin P, Yan L.

Oncotarget. 2017 Aug 24;8(53):91343-91349. doi: 10.18632/oncotarget.20514. eCollection 2017 Oct 31.

3.

Targeting of PHOX2B expression allows the identification of drugs effective in counteracting neuroblastoma cell growth.

Di Zanni E, Bianchi G, Ravazzolo R, Raffaghello L, Ceccherini I, Bachetti T.

Oncotarget. 2017 Aug 4;8(42):72133-72146. doi: 10.18632/oncotarget.19922. eCollection 2017 Sep 22.

4.

Genetic Variations of GWAS-Identified Genes and Neuroblastoma Susceptibility: a Replication Study in Southern Chinese Children.

He J, Zou Y, Wang T, Zhang R, Yang T, Zhu J, Wang F, Xia H.

Transl Oncol. 2017 Dec;10(6):936-941. doi: 10.1016/j.tranon.2017.09.008. Epub 2017 Oct 9.

5.

Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.

Yang XH, Tang F, Shin J, Cunningham JM.

BMC Syst Biol. 2017 Oct 3;11(Suppl 5):92. doi: 10.1186/s12918-017-0466-5.

6.

Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.

Chang X, Zhao Y, Hou C, Glessner J, McDaniel L, Diamond MA, Thomas K, Li J, Wei Z, Liu Y, Guo Y, Mentch FD, Qiu H, Kim C, Evans P, Vaksman Z, Diskin SJ, Attiyeh EF, Sleiman P, Maris JM, Hakonarson H.

Nat Commun. 2017 Sep 18;8(1):569. doi: 10.1038/s41467-017-00408-8.

7.

BARD1 serum autoantibodies for the detection of lung cancer.

Pilyugin M, Descloux P, André PA, Laszlo V, Dome B, Hegedus B, Sardy S, Janes S, Bianco A, Laurent GJ, Irminger-Finger I.

PLoS One. 2017 Aug 7;12(8):e0182356. doi: 10.1371/journal.pone.0182356. eCollection 2017.

8.

The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.

Capasso M, McDaniel LD, Cimmino F, Cirino A, Formicola D, Russell MR, Raman P, Cole KA, Diskin SJ.

J Cell Mol Med. 2017 Dec;21(12):3224-3230. doi: 10.1111/jcmm.13226. Epub 2017 Jun 30.

9.

Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.

McDaniel LD, Conkrite KL, Chang X, Capasso M, Vaksman Z, Oldridge DA, Zachariou A, Horn M, Diamond M, Hou C, Iolascon A, Hakonarson H, Rahman N, Devoto M, Diskin SJ.

PLoS Genet. 2017 May 18;13(5):e1006787. doi: 10.1371/journal.pgen.1006787. eCollection 2017 May.

10.

Genetic susceptibility to neuroblastoma.

Tolbert VP, Coggins GE, Maris JM.

Curr Opin Genet Dev. 2017 Feb;42:81-90. doi: 10.1016/j.gde.2017.03.008. Epub 2017 Apr 28. Review.

PMID:
28458126
11.

HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population.

Zhang Z, Zou Y, Zhu J, Zhang R, Yang T, Wang F, Xia H, He J, Feng Z.

Onco Targets Ther. 2017 Apr 4;10:1969-1975. doi: 10.2147/OTT.S136006. eCollection 2017.

12.

A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).

Yang XH, Tang F, Shin J, Cunningham JM.

Sci Rep. 2017 Mar 3;7(1):41. doi: 10.1038/s41598-017-00122-x.

13.

Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population.

Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H.

Onco Targets Ther. 2017 Feb 8;10:703-709. doi: 10.2147/OTT.S129042. eCollection 2017.

14.

The association between gene SNPs and cancer predisposition: Correlation or causality?

Tan H.

EBioMedicine. 2017 Feb;16:8-9. doi: 10.1016/j.ebiom.2017.01.047. Epub 2017 Feb 1. No abstract available.

15.

BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.

Fu W, Zhu J, Xiong SW, Jia W, Zhao Z, Zhu SB, Hu JH, Wang FH, Xia H, He J, Liu GC.

EBioMedicine. 2017 Feb;16:101-105. doi: 10.1016/j.ebiom.2017.01.038. Epub 2017 Jan 31.

16.

Research progress of neuroblastoma related gene variations.

Cao Y, Jin Y, Yu J, Wang J, Yan J, Zhao Q.

Oncotarget. 2017 Mar 14;8(11):18444-18455. doi: 10.18632/oncotarget.14408. Review.

17.

Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.

Salazar BM, Balczewski EA, Ung CY, Zhu S.

Int J Mol Sci. 2016 Dec 27;18(1). pii: E37. doi: 10.3390/ijms18010037. Review.

18.

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.

Pilyugin M, André PA, Ratajska M, Kuzniacka A, Limon J, Tournier BB, Colas J, Laurent G, Irminger-Finger I.

Oncotarget. 2017 Feb 7;8(6):9339-9353. doi: 10.18632/oncotarget.14068.

19.

Lack of Associations between XPC Gene Polymorphisms and Neuroblastoma Susceptibility in a Chinese Population.

Zheng J, Zhang R, Zhu J, Wang F, Yang T, He J, Xia H.

Biomed Res Int. 2016;2016:2932049. Epub 2016 Oct 26.

20.

The zebrafish as a model for studying neuroblastoma.

Corallo D, Candiani S, Ori M, Aveic S, Tonini GP.

Cancer Cell Int. 2016 Nov 3;16:82. eCollection 2016. Review.

Supplemental Content

Support Center